B-lymphoblastic leukemia/lymphoma with t(9;22)(q34.1;q11.2)
MONDO:0035940Also known as: B-ALL with t(9;22)(q34.1;q11.2), BCR-ABL1-like B-ALL, Philadelphia chromosome-like B-ALL
1895 clinical trials for this condition and its sub-types, 51 tagged with B-lymphoblastic leukemia/lymphoma with t(9;22)(q34.1;q11.2) itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →-
Can a Chemo-Antibody combo beat a tough leukemia?
Cure Stopped earlyThis phase II trial is testing whether adding the targeted antibody-drug inotuzumab ozogamicin to a standard chemotherapy regimen (Hyper-CVAD) improves outcomes for adults with B-cell acute lymphoblastic leukemia. The study enrolls people with newly diagnosed or recently remitted…
Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Cure
Last updated Aug 01, 2026 00:00 UTC
-
New drug combo for kids with resistant leukemia shows early promise but study halted
Disease control Stopped earlyThis study tested a targeted cancer drug called ponatinib combined with standard chemotherapy in children and young adults up to age 21 with Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) that had come back or stopped responding to other treatments. The g…
Phase 1/2 • Sponsor: Takeda • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC